Chief Operating Officer of Homology Medicines, Inc. (U.S.: Nasdaq:FIXX), Kelly Timothy P, sells 1,406 shares worth $5,315
According to Homology Medicines, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 04:05 PM, company Chief Operating Officer, Kelly Timothy P disclosed selling 1,406 shares at a cost of $3.78. At the time of this transaction (Jan 05), this trade was worth $5,315 in total. As of Jan 05, Kelly Timothy P now owns 2,224 shares in total worth about $8,173.2.
For the last few recent trades made by Homology Medicines, Inc. (U.S.: Nasdaq:FIXX) Chief Operating Officer, Kelly Timothy P, we have the following information:
- SEC Form 4 filing: Sep 03: Sold 54 shares at the rate of $7.70 per share. Total worth of this trade was $416. Total number of shares owned as of Sep 03 were 0
- SEC Form 4 filing: Feb 02: Sold 500 shares at the rate of $13.00 per share. Total worth of this trade was $6,500. Total number of shares owned as of Feb 02 were 0
- SEC Form 4 filing: Feb 01: Sold 4,000 shares at the rate of $12.37 per share. Total worth of this trade was $49,460. Total number of shares owned as of Feb 01 were 0
Posted by
George Daniels
on Thursday January 13 2022, 1:29 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
